Resilience of transfluthrin to oxidative attack by duplicated CYP6P9 variants known to confer pyrethroid resistance in the major malaria mosquito Anopheles funestus

• Published in: Pesticide biochemistry and physiology Vol. 191; p. 105356
• Main Authors: Nolden, Melanie, Velten, Robert, Paine, Mark J.I., Nauen, Ralf
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-04-2023
• Subjects: Animals; Anopheles; Anopheles - genetics; Chromatography, Liquid; CYP6P9a; CYP6P9b; Cytochrome P450; Insecticide Resistance - genetics; Insecticides - metabolism; Insecticides - pharmacology; Malaria; Mosquito Vectors - genetics; Oxidative Stress; Permethrin - pharmacology; Pyrethrins - metabolism; Pyrethrins - pharmacology; Pyrethroids; Tandem Mass Spectrometry; Transfluthrin; Pyrethroids; Anopheles; CYP6P9b; Transfluthrin; CYP6P9a; Cytochrome P450
• ISSN: 0048-3575; 1095-9939
• DOI: 10.1016/j.pestbp.2023.105356

Resistance to common pyrethroids, such as deltamethrin and permethrin is widespread in the malaria mosquito Anopheles funestus and mainly conferred by upregulated cytochrome P450 monooxygenases (P450s). In the pyrethroid resistant laboratory strain An. funestus FUMOZ-R the duplicated genes CYP6P9a and CYP6P9b are highly upregulated and have been shown to metabolize various pyrethroids, including deltamethrin and permethrin. Here, we recombinantly expressed CYP6P9a and CYP6P9b from An. funestus using a baculovirus expression system and evaluated the interaction of the multifluorinated benzyl pyrethroid transfluthrin with these enzymes by different approaches. First, by Michaelis-Menten kinetics in a fluorescent probe assay with the model substrate 7-benzyloxymethoxy-4-trifluoromethylcoumarin (BOMFC), we showed the inhibition of BOMFC metabolism by increasing concentrations of transfluthrin. Second, we tested the metabolic capacity of recombinantly expressed CYP6P9 variants to degrade transfluthrin utilizing UPLC-MS/MS analysis and detected low depletion rates, explaining the virtual lack of resistance of strain FUMOZ-R to transfluthrin observed in previous studies. However, as both approaches suggested an interaction of CYP6P9 variants with transfluthrin, we analyzed the oxidative metabolic fate and failed to detect hydroxylated transfluthrin, but low amounts of an M-2 transfluthrin metabolite. Based on the detected metabolite we hypothesize oxidative attack of the gem-dimethyl substituted cyclopropyl moiety, resulting in the formation of an allyl cation upon ring opening. In conclusion, these findings support the resilience of transfluthrin to P450-mediated pyrethroid resistance, and thus, reinforces its employment as an important resistance-breaking pyrethroid in resistance management strategies to control the major malaria vector An. funestus.
[Display omitted]
•CYP6P9 variants of An. funestus weakly interact with transfluthrin.•CYP6P9 kinetics revealed mixed-type inhibition of BOMFC O-debenzylation by transfluthrin.•UPLC-MS/MS analysis suggest hydroxylation of the cyclopropyl gem-dimethyl group.•Elimination of a hydroxide ion results in a stable M-2 metabolite (atomic mass units 369).